Cipla Ltd. (Unit II)
UkraineAll drugs from this manufacturer
-
The drug is used for the treatment of bronchial asthma, relief of acute wheezing attacks, alleviation of wheezing, as well as for the prevention of asthma before physical exertion or exacerbations.
Dosage form: aerosol, suspension for inhalation
Active substance Dosage salbutamol 100 mcg ATC: R03AC02
-
The drug is used for the treatment of bronchial asthma (as an adjunct to corticosteroids) and to reduce symptoms of airway obstruction in chronic obstructive pulmonary disease (COPD).
Dosage form: aerosol, suspension for inhalation
Active substance Dosage formoterol 12 mcg ATC: R03AC13
-
The drug is used for regular add-on treatment of asthma (including nocturnal attacks), for the treatment of chronic obstructive pulmonary disease (COPD), and for the prevention of exercise-induced asthma attacks.
Dosage form: inhalation, suspension under pressure
Active substance Dosage salmeterol 25 mcg per dose ATC: R03AC12
-
The drug is intended for the regular treatment of bronchial asthma in patients who require combination therapy (a combination of long-acting active substances and corticosteroids).
Dosage form: aerosol, metered dose for inhalation
Active substance Dosage salmeterol 25 mcg fluticasone 125 mcg ATC: R03AK06
-
The drug is intended for the regular treatment of bronchial asthma in patients who require combination therapy with long-acting β2-adrenoceptor agonists and inhaled corticosteroids.
Dosage form: aerosol, metered dose for inhalation
Active substance Dosage salmeterol 25 mcg fluticasone 250 mcg ATC: R03AK06
-
The drug is intended for the regular treatment of bronchial asthma in patients who require combination therapy with long-acting β2-adrenoceptor agonists and inhaled corticosteroids.
Dosage form: aerosol, metered dose for inhalation
Active substance Dosage salmeterol 25 mcg fluticasone 50 mcg ATC: R03AK06